We are a developer of live engineered biotherapetics focused on gastrointestinal diseases using engrafting native chassis expressing therapeutic proteins
FOR IMMEDIATE RELEASE
Endure Biotherapeutics Receives SBIR Phase I Grant to Advance Engineered Native Bacteria Therapy for Familial Adenomatous Polyposis.
I am very happy to share our recent review article on Methods of DNA introduction for the engineering of commensal microbes. Congrats to Dake, Nicole and thanks to excellent collaboration with @Zarrinparlab and to support from @NCI. https://t.co/l13keBozq5
Thank you Director Tabak! Endure Bio is developing Zarrinpar Laboratory's technology to treat chronic conditions. Watch this page!! Go Endure Bio! Live engrafting biotherapeutics!
Professor Amir Zarrinpar's seminal paper on engraftable live biotherapeutics is out!! We are commercializing this potentially curative engrafting technology at Endure Bio.
https://t.co/upy8AROyzZ